Modified peanut oral immunotherapy protocol safely and effectively induces desensitization

Journal of Allergy and Clinical Immunology: In Practice

Volumn 3, Issue 3, 2015, Pages 433-435.e3

  Bird, J Andrew ^a   Feldman, Matthew ^a   Arneson, Amy ^b   Dougherty, Irene ^a   Brown, L Steven ^a   Burk, Caitlin M ^c   Kulis, Michael ^c   Burks, Wesley ^c   Gill, Michelle ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEANUT PROTEIN; UNCLASSIFIED DRUG; VEGETABLE PROTEIN; ALLERGEN;

ALLERGIC REACTION; CLINICAL PROTOCOL; DESENSITIZATION; HUMAN; LETTER; MAINTENANCE DRUG DOSE; ORAL IMMUNOTHERAPY; PEANUT ALLERGY; PEANUT ORAL IMMUNOTHERAPY; PILOT STUDY; PRICK TEST; PROVOCATION TEST; ADVERSE EFFECTS; ARACHIS; CLINICAL TRIAL; DOSE CALCULATION; IMMUNOLOGY; INTRACUTANEOUS TEST; NUT; ORAL DRUG ADMINISTRATION; PEANUT HYPERSENSITIVITY; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ALLERGENS; ARACHIS; DESENSITIZATION, IMMUNOLOGIC; DRUG DOSAGE CALCULATIONS; HUMANS; INTRADERMAL TESTS; NUTS; PEANUT HYPERSENSITIVITY; PILOT PROJECTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84939783262     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.11.020     Document Type: Article

References (6)

1. Jones S.M., Pons L., Roberts J.L., Scurlock A.M., Perry T.T., Kulis M., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009, 124:292-300. e1-97.
2. Varshney P., Jones S.M., Scurlock A.M., Perry T.T., Kemper A., Steele P., et al. A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011, 127:654-660.
3. Anagnostou K., Islam S., King Y., Foley L., Pasea L., Bond S., et al. Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet 2014, 383:1297-1304.
4. Blumchen K., Ulbricht H., Staden U., Dobberstein K., Beschorner J., de Oliveira L.C., et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 2010, 126:83-91. e1.
5. Hofmann A.M., Scurlock A.M., Jones S.M., Palmer K.P., Lokhnygina Y., Steele P.H., et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 2009, 124:286-291. 291.e1-6.
6. Begin P., Dominguez T., Wilson S.P., Bacal L., Mehrotra A., Kausch B., et al. Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using omalizumab. Allergy Asthma Clin Immunol 2014, 10:7.